The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug Blenrep, when used in combination with other treatments, may cause eye damage in ...

Longer axial lengths, preoperative glaucoma drop use appear to raise the risk for hypotony following vitrectomy for epiretinal membrane.